title: Anaphylactic reactions associated with omalizumab administration: Analysis of a case-control study.
authors.affiliation: Departments of Internal Medicine and Pediatrics, Divisions of Allergy and Immunology, University of Tennessee College of Medicine, Memphis, Tenn. Electronic address: phillieberman@hotmail.com.
authors.forename: Phillip L
authors.initials: PL
authors.lastname: Lieberman
authors.affiliation: Global Product Development, Genentech, Inc, South San Francisco, Calif.
authors.forename: Dale T
authors.initials: DT
authors.lastname: Umetsu
authors.affiliation: Real World Data Science, Genentech, Inc, South San Francisco, Calif.
authors.forename: Gillis J
authors.initials: GJ
authors.lastname: Carrigan
authors.affiliation: Global Product Development, Genentech, Inc, South San Francisco, Calif.
authors.forename: Abdelkader
authors.initials: A
authors.lastname: Rahmaoui
mesh_terms: D000328:Adult; D000707:Anaphylaxis / Q000139:chemically induced*; D018926:Anti-Allergic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D018927:Anti-Asthmatic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D001249:Asthma / Q000188:drug therapy; D016022:Case-Control Studies; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D000069444:Omalizumab / Q000009:adverse effects* / Q000627:therapeutic use
chemical_list: D018926:Anti-Allergic Agents; D018927:Anti-Asthmatic Agents; D000069444:Omalizumab